In the case of IL-33, its expression tends to be elevated during the early stages of tumor development but decreases in more advanced and poorly differentiated tumors, indicating a possible dual role—initially protective, followed by a shift toward tumor promotion in later stages [44]. This evidence concerns the gene IL33 and neoplasm.